Newsletters

Spring 2007

My Experience in Research
Voices from Volunteers

I am currently in a clinical trial for an Amgen treatment for osteoporosis. This is the third clinical trial in which I have participated during the last seven years, and I have found my participation to be rewarding for several reasons.

First, it gives me the chance to try a new medication when I have run out of viable options. In a previous trial for arthritis treatment, the drug I received is now my medication of choice.

Second, I feel that I am contributing valuable information for the development of new pharmaceuticals and for genetic research.  This gives me good feelings!

Third, the regular tests and exams I get are certainly worthwhile. Even though the results are blinded, I'm sure that if anything was found to be out of line I'd hear about it!

Fourth, I have been able to pass on information I have gained to friends and relatives who suffer from the same conditions that afflict me.

I would certainly consider participating in more trials that are relevant to my health.

My experience at the New Mexico Clinical Research and Osteoporosis Center has been most enjoyable. All the staff members I have met are very pleasant and really seem to care about my well being.

Janet D. Trauth
March 5, 2007

I have been in a study with Dr. Lewiecki for 3-1/2 years.  I have enjoyed meeting all of the staff and becoming more educated about osteoporosis.   If I ever had any questions regarding the study or how I felt about any tests, I was fully satisfied with the explanation from a study coordinator or doctor.

I have had very little discomfort from the IV infusions of study medication and the bone biopsy I had done at the end of the first 3-year study.  I do hope this study is successful, this would mean it could benefit many in the future. The benefits are a decreased rate of bone loss, which may also reduce fractures.

I have told many of my friends about the study and the possible benefits that may result for all participants. I recommend that all participants continue with the study. I encourage anyone that qualifies to join a study group.

Margaret Cole
March 20, 2007